Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors

被引:50
作者
Intagliata, Sebastiano [1 ]
Salerno, Loredana [1 ]
Ciaffaglione, Valeria [1 ]
Leonardi, Carmen [1 ]
Fallica, Antonino N. [1 ]
Carota, Giuseppe [1 ]
Amata, Emanuele [1 ]
Marrazzo, Agostino [1 ]
Pittala, Valeria [1 ]
Romeo, Giuseppe [1 ]
机构
[1] Univ Catania, Dept Drug Sci, Viale A Doria 6, I-95125 Catania, Italy
关键词
Heme oxygenase-2; Heme oxygenase-1; Imidazole derivatives; Activators; Azalanstat; Clemizole; Structure-activity relationships; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; IMIDAZOLE-DIOXOLANE COMPOUNDS; EARLY REPRESSOR ICER; IN-VITRO INHIBITION; CARBON-MONOXIDE; REGULATORY MOTIFS; OXIDATIVE STRESS; SELECTIVE-INHIBITION; BILIVERDIN REDUCTASE; HYDROGEN-SULFIDE;
D O I
10.1016/j.ejmech.2019.111703
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Heme oxygenase (HO) enzymes are involved in heme catabolism and several physiological functions. Among the different HO isoforms, HO-2 stands out for its neuroprotective properties and modulatory activity in male reproduction. However, unlike the HO-1 ligands, the potential therapeutic applications of HO-2 inhibitors/activators have not been extensively explored yet. Moreover, the physiological role of HO-2 is still unclear, mostly due to the lack of highly selective HO-2 chemical probes. To boost the interest on this intriguing target, the present review updates the knowledge on the structure-activity relationships of HO-2 inhibitors and activators, as well as their potential therapeutic applications. To the best of our knowledge, among HO-2 inhibitors, clemizole derivatives are the most selective HO-2 inhibitors reported so far (IC50 HO-1 >100 mu M, IC50 HO-2 = 3.4 mu M), while the HO-2 nonselective inhibitors described herein possess IC50 HO-2 values < 10 mu M. Furthermore, the development of HO-2 activators, such as menadione analogues, helped to understand the critical moieties required for HO-2 activation. Recent advances in the potential therapeutic applications of HO-2 inhibitors/activators cover the fields of neurodegenerative, cardiovascular, inflammatory, and reproductive diseases further stimulating the interest towards this target. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:16
相关论文
共 140 条
[41]   Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products [J].
Floresta, Giuseppe ;
Amata, Emanuele ;
Gentile, Davide ;
Romeo, Giuseppe ;
Marrazzo, Agostino ;
Pittala, Valeria ;
Salerno, Loredana ;
Rescifina, Antonio .
MARINE DRUGS, 2019, 17 (02)
[42]   Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis [J].
Floresta, Giuseppe ;
Pittala, Valeria ;
Sorrenti, Valeria ;
Romeo, Giuseppe ;
Salerno, Loredana ;
Rescifina, Antonio .
BIOORGANIC CHEMISTRY, 2018, 81 :334-339
[43]   Identification of Potentially Potent Heme Oxygenase1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis [J].
Floresta, Giuseppe ;
Amata, Emanuele ;
Dichiara, Maria ;
Marrazzo, Agostino ;
Salerno, Loredana ;
Romeo, Giuseppe ;
Prezzavento, Orazio ;
Pittala, Valeria ;
Rescifina, Antonio .
CHEMMEDCHEM, 2018, 13 (13) :1336-1342
[44]   Diagnostic criteria for Parkinson disease [J].
Gelb, DJ ;
Oliver, E ;
Gilman, S .
ARCHIVES OF NEUROLOGY, 1999, 56 (01) :33-39
[45]   The identification and expression of heme oxygenase-2 alternative transcripts in the mouse [J].
Gibbs, L ;
Willis, D ;
Morgan, MJ .
GENE, 1998, 221 (02) :171-177
[46]   Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction [J].
Goodman, Alvin I. ;
Chander, Praveen N. ;
Rezzani, Rita ;
Schwartzman, Michal L. ;
Regan, Raymond F. ;
Rodella, Luigi ;
Turkseven, Saadet ;
Lianos, Elias A. ;
Dennery, Phyllis A. ;
Abraham, Nader G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04) :1073-1081
[47]   Quantitative imaging mass spectroscopy reveals roles of heme oxygenase-2 for protecting against transhemispheric diaschisis in the brain ischemia [J].
Goto, Shinichi ;
Morikawa, Takayuki ;
Kubo, Akiko ;
Takubo, Keiyo ;
Fukuda, Keiichi ;
Kajimura, Mayumi ;
Suematsu, Makoto .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2018, 63 (01) :70-79
[48]  
Greish K.F., 2018, MOLECULES, P23
[49]  
Gupta A., 2011, Patent No. [US20090176831A1, 20090176831]
[50]   IRON PROMOTERS OF THE FENTON REACTION AND LIPID-PEROXIDATION CAN BE RELEASED FROM HEMOGLOBIN BY PEROXIDES [J].
GUTTERIDGE, JMC .
FEBS LETTERS, 1986, 201 (02) :291-295